Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04652076
Title GYNecological Cancers Treated With NETrin mAbs in Combination With Chemotherapy and /or Pembrolizumab (GYNET)
Recruitment Recruiting
Gender female
Phase Phase Ib/II
Variant Requirements No
Sponsors NETRIS Pharma
Indications

cervical adenocarcinoma

endometrial carcinoma

cervical squamous cell carcinoma

Therapies

Carboplatin + NP137 + Paclitaxel Trevatide + Pembrolizumab

NP137 + Pembrolizumab

Carboplatin + NP137 + Paclitaxel

Carboplatin + Paclitaxel

Age Groups: adult | senior
Covered Countries FRA


No variant requirements are available.